(0.04%) 5 216.18 points
(0.23%) 39 480 points
(-0.17%) 16 319 points
(-1.14%) $78.36
(-1.78%) $2.26
(1.47%) $2 374.70
(0.66%) $28.55
(1.72%) $1 007.85
(0.07%) $0.928
(-0.21%) $10.84
(-0.08%) $0.798
(0.12%) $92.66
2 days till quarter result
(bmo 2024-05-12)
Expected move: +/- 5.35%
Live Chart Being Loaded With Signals
Shalby Limited operates multi-specialty hospitals primarily in India. The company offers arthroscopy, arthroplasty, cardiology, cardiothoracic and vascular surgery, cosmetic and aesthetic, dental cosmetic and implant ology, emergency medicine, endocrinology, endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, general medicine and surgery, hair transplant, liver disease and transplant, and hip and knee joint replacement services...
Stats | |
---|---|
Today's Volume | 124 269 |
Average Volume | 241 337 |
Market Cap | 29.27B |
EPS | INR0 ( 2024-02-12 ) |
Next earnings date | ( INR0 ) 2024-05-12 |
Last Dividend | INR1.200 ( 2023-08-08 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 35.84 |
ATR14 | INR0.459 (0.17%) |
Volume Correlation
Shalby Limited Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Shalby Limited Correlation - Currency/Commodity
Shalby Limited Financials
Annual | 2022 |
Revenue: | INR8.05B |
Gross Profit: | INR3.70B (45.94 %) |
EPS: | INR6.30 |
FY | 2022 |
Revenue: | INR8.05B |
Gross Profit: | INR3.70B (45.94 %) |
EPS: | INR6.30 |
FY | 2022 |
Revenue: | INR6.99B |
Gross Profit: | INR3.05B (43.58 %) |
EPS: | INR6.46 |
FY | 2021 |
Revenue: | INR4.31B |
Gross Profit: | INR1.81B (42.07 %) |
EPS: | INR4.71 |
Financial Reports:
No articles found.
Shalby Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR1.000 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR1.200 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.500 | 2019-08-16 |
Last Dividend | INR1.200 | 2023-08-08 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | INR4.20 | -- |
Avg. Dividend % Per Year | 0.51% | -- |
Score | 1.91 | -- |
Div. Sustainability Score | 3.43 | |
Div.Growth Potential Score | 4.27 | |
Div. Directional Score | 3.85 | -- |
Year | Amount | Yield |
---|---|---|
2019 | INR0.500 | 0.34% |
2020 | INR0.500 | 0.54% |
2021 | INR1.000 | 0.92% |
2022 | INR1.000 | 0.70% |
2023 | INR1.200 | 0.79% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RSWM.NS | Dividend Junior | 2023-09-08 | Sporadic | 23 | 1.41% | |
LICI.NS | No Dividend Player | 2023-07-20 | Annually | 3 | 0.17% | |
GANDHITUBE.NS | Dividend Junior | 2023-07-28 | Annually | 17 | 1.82% | |
APOLSINHOT.NS | Dividend Junior | 2023-09-22 | Annually | 10 | 0.11% | |
TEGA.NS | Dividend Junior | 2023-08-17 | Insufficient data to determine frequency | 2 | 0.12% | |
ONGC.NS | Dividend Knight | 2023-08-18 | Semi-Annually | 28 | 4.00% | |
INTENTECH.NS | Dividend Junior | 2023-09-21 | Annually | 6 | 0.44% | |
COROMANDEL.NS | Dividend Knight | 2023-07-13 | Annually | 19 | 1.02% | |
SHARDACROP.NS | Dividend Junior | 2023-08-01 | Semi-Annually | 10 | 0.97% | |
MANAPPURAM.NS | Dividend Knight | 2023-08-23 | Quarterly | 15 | 1.17% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0916 | 1.500 | 8.17 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.0860 | 1.500 | -0.155 | -0.233 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 10.77 | 1.000 | 7.12 | 7.12 | [3 - 30] |
operatingCashFlowPerShareTTM | 6.92 | 2.00 | 7.69 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 6.92 | 2.00 | 6.54 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.464 | 1.000 | 5.60 | 5.60 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.150 | 1.000 | 9.00 | 9.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 3.43 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 35.99 | 1.000 | 6.47 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0860 | 2.50 | -0.0997 | -0.233 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 6.92 | 2.00 | 7.69 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.439 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 6.92 | 2.00 | 7.69 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.310 | 1.500 | 4.60 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0834 | 1.000 | -0.415 | 0 | [0.1 - 0.5] |
Total Score | 4.27 |
Shalby Limited
Shalby Limited operates multi-specialty hospitals primarily in India. The company offers arthroscopy, arthroplasty, cardiology, cardiothoracic and vascular surgery, cosmetic and aesthetic, dental cosmetic and implant ology, emergency medicine, endocrinology, endoscopy and laparoscopy, ENT surgery, gastroentero surgery, gastroenterology, general medicine and surgery, hair transplant, liver disease and transplant, and hip and knee joint replacement services. It also provides infectious disease, infertility and IVF, intensive and critical care, maxillofacial surgery, nephrology, neuro surgery, neurology, obesity surgery, obstetrics and gynecology, oncology, oncosurgery, ophthalmology and glaucoma, orthopedic and trauma, pediatric orthopedic, pathology and microbiology, pediatrics and neonatology, plastic surgery, pulmonology and chest, radiology and imaging, rheumatology, trauma, organ donation, and urosurgery services. The company operates 11 hospitals comprising aggregate capacity of 2,012 beds. In addition, it offers outpatient services through 50 outpatient clinics, as well as provides educational programs and fellowships for paramedical students and other healthcare professionals; and homecare health services, such as attendants, doctors, nursing, physiotherapy, pathology, pharmacy, and medical equipment, as well as conducts clinical research trials. It also operates in Kenya, Tanzania, Rwanda, Uganda, the United Arab Emirates, Bangladesh, Cambodia, Jakarta, Oman, Uzbekistan, Nepal, and internationally. The company was formerly known as Shalby Hospitals Limited and changed its name to Shalby Limited in February 2008. Shalby Limited was founded in 1994 and is headquartered in Ahmedabad, India.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators